Search for: "Eli Lilly " Results 681 - 700 of 2,134
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
30 Nov 2013, 12:37 pm by Howard Knopf
Among other things, he provides frank, wise,and often witty remarks on:leave applications, including the recent rare example of oral argument in the Eli Lilly casethe use of a "glossary" in factumsthe dangers of using disrespectful rhetoricthe relative importance of written arguments and some very good tips on how to write themthe recent development of a conference amongst the judges 15 minutes before the hearingthe recent changes in intervener factum lengths and time limitssome… [read post]
11 Dec 2021, 8:25 pm by Patent Docs
Patent and Trademark Office; Mark Stewart of Eli Lilly and Co.; and Todd Walters of Buchanan Ingersoll & Rooney PC will discuss the best practices and emerging trends from pre-institution through final hearing, including strategies focused on petition drafting, preliminary patent owner responses, discretionary denial considerations,... [read post]
11 Aug 2018, 9:08 pm by Patent Docs
Eli Lilly • Implications on antibody patent scope • Effects... [read post]
16 Aug 2014, 6:36 pm by Howard Friedman
This week, Christ Church, an Episcopal Church in Indianapolis, Indiana, filed suit against JP Morgan Chase alleging mishandling of the church's $35 million trust whose assets came originally from gifts from Eli Lilly, Jr. [read post]
6 Apr 2024, 8:49 pm by Patent Docs
This year's conference co-chairs include Andrei Iancu (Partner, Sullivan & Cromwell LLP and former Director of the USPTO), Brian Malkin (Associate General Counsel, Teva Pharmaceuticals), and Mira Mulvaney (Assistant General Patent Counsel, IP Litigation, Eli Lilly & Company). [read post]
16 Oct 2018, 12:20 pm by Steve Brachmann
The last case was a summary affirmance of a victory by German drugmaker Erfindergemeinschaft UroPep over Eli Lilly in the Eastern District of Texas. [read post]
2 Dec 2022, 11:15 am by Steve Brachmann
Food and Drug Administration halts authorization for Eli Lilly’s COVID-19 treatment for lack of effectiveness against dominant Omicron subvariants; and more. [read post]
11 Apr 2014, 7:57 am
Both defendants, Takeda Pharmaceuticals Co. and Eli Lilly & Co., insists that their medication is safe and they plan to appeal the jury's verdict. [read post]
2 Oct 2023, 9:32 pm by Patent Docs
Eli Lilly & Co., which (in the view of many) heightened the written description requirement for biotechnology inventions. [read post]
29 Sep 2018, 8:09 pm by Patent Docs
True Health Diagnostics LLC -- Eli Lilly & Co. v. [read post]
25 May 2014, 8:07 pm by Patent Docs
The program will consist of two panels: • Panel 1: Eli Lilly and the Canadian NAFTA Challenge -- panel includes Patent Docs author Andrew Williams of McDonnell Boehnen Hulbert & Berghoff LLP • Panel 2: Secondary Use Patents: A Comparative View Additional information about the program, including registration/CLE information... [read post]
2 Nov 2011, 12:57 pm
Still, you can’t blame the inventor for trying… The dispute in Human Genome Sciences v Eli Lilly is, by comparison, a whole other kettle of fish. [read post]
12 Jul 2011, 6:59 am by randal shaheen
The Southern District of California did an about-face after granting a TRO, and denied a preliminary injunction to stop Eli Lilly & Co from using the same 700-person sales force to market rival drugs. [read post]
28 Oct 2011, 7:22 am
IN - Judge Tanya Walton Pratt of the Southern District of Indiana has granted a Partial Summary Judgment for Eli Lilly and Company of Indianapolis, Indiana in a dispute with licensee Valeant Pharmaceuticals International of Irvine, California involving the costs associated with product liability lawsuits over Lilly's Parkinson's disease drug. [read post]
17 Dec 2008, 9:48 am
 Durch die Entscheidung  wurde ein Patent des Unternehmens Eli Lilly and Co Ltd., welches den pharmazeutischen Wirkstoff “Olanzapin” betrifft, für nichtig erklärt. [read post]
19 Feb 2019, 5:03 am by Orin France
Indiana’s Senate Public Policy Committee voted 9-1 in favor of a hate crime bill after a three-hour hearing that featured testimony in support of the bill by several of Indiana’s more prominent corporate citizens, including the Indiana Pacers basketball team, the Indianapolis Colts football team, Eli Lilly and Co., Anthem Healthcare and the Indiana Chamber of Commerce. [read post]